Liver Sarcoma — Clinical Trials

MONDO:00023974 active·3 recruitingLast updated: Mar 15, 2026, 8:20 PM

Trial Landscape

Liver Sarcoma has an emerging clinical trial program, driven by gene therapy and biological therapy.

Recruiting

Active Trials

By Approach

Gene Therapy2

Biological Therapy1

1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 1

1 trials are observational or have no phase designation.

Sponsor Types

Academic/Other4

Trial Locations

United States4 trials

Trials often recruit across multiple countries, so totals exceed the trial count.

3 of 4 Trials

Phase 1Recruiting

NCT07148050

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Sponsor:Seattle Children's Hospital

United StatesStarted: Dec 2025Est. completion: Apr 2044Updated: Feb 2026

Phase 1Recruiting

NCT06198296

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Sponsor:Baylor College of Medicine

United StatesStarted: Jun 2025Est. completion: Feb 2043Updated: Nov 2025

Phase 1Active, Not Recruiting

NCT05103631

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

Sponsor:Baylor College of Medicine

United StatesStarted: Jun 2021Est. completion: Dec 2040Updated: Mar 2026

Stay informed about clinical trials for Liver Sarcoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 15, 2026 at 8:20 PM